drugset / Trial / NCT03735680
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
This study is to evaluate diagnostic performance, safety and timing of post-dose imaging of ONM-100, an intraoperative fluorescence imaging agent for the detection of cancer in patients with solid tumors undergoing routine surgery.
Timeline
- Start
- 2019-08-09
- Primary completion
- 2021-10-14
- Completion
- 2021-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pegsitacianine | Diagnostic / imaging agent | — | — |